Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PATH vs MRNA✓SelectedUSD · MRNAPATH vs MRNA performance historyLatest closeAs of-5.71%11/17
Stock and ETF performance explorer

PATH vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-8.4%
MRNA return
+744.1%
Excess return
-752.4%
Maximum drawdown
-51.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-5.7%-3.9%-1.8%-5.6%
7D-3.4%-17.6%+14.1%-3.0%
30D-3.6%-5.1%+1.6%-3.5%
3M-22.5%+220.8%-243.3%-25.3%
6M+20.6%+321.7%-301.1%+12.7%
YTD-24.4%+601.3%-625.7%-36.6%
1Y-8.4%+735.2%-743.6%-26.5%
All-8.4%+744.1%-752.4%-26.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling